resveratrol has been researched along with 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Boocock, D; Farmer, PB; Gescher, AJ; Jones, DJ; Potter, GA; Ruparelia, KC; Sale, S; Steward, WP; Verschoyle, RD; Wilsher, N | 1 |
| Chen, KY; Chen, M; Gosslau, A; Ho, CT | 1 |
| Gescher, AJ; Potter, GA; Ruparelia, KC; Sale, S; Steward, WP; Tunstall, RG | 1 |
| Gossage, RA; Haddadi, A; Lai, R; Lavasanifar, A; Ma, Z; Molavi, O | 1 |
| Chen, LK; Dai, F; Qiang, PF; Xu, QP; Zhang, L; Zhao, YH | 1 |
| Amarowicz, R; Jodynis-Liebert, J; Kulcenty, K; Murias, M; Myszkowski, K; Piotrowska, H; Wierzchowski, M | 1 |
| Crooks, PA; Penthala, NR; Thakkar, S | 1 |
| Ignatowicz, E; Jodynis-Liebert, J; Krajka-Kuźniak, V; Kujawska, M; Murias, M; Nowicki, M; Petzke, E; Piotrowska, H; Wierzchowski, M; Zawierucha, P | 1 |
| Borys, S; Jodynis-Liebert, J; Kaczmarek, M; Kucińska, M; Murias, M; Piotrowska-Kempisty, H; Ruciński, M; Wierzchowski, M; Zawierucha, P; Łażewski, D | 1 |
| Bachleda, P; Dvořák, Z; Pastorková, B; Vrzalová, A | 1 |
| Jodynis-Liebert, J; Jozkowiak, M; Krajka-Kuzniak, V; Nowicki, A; Piotrowska-Kempisty, H; Ramlau, P; Rucinski, M; Skupin-Mrugalska, P; Wierzchowski, M | 1 |
| Czajkowski, M; Józkowiak, M; Nowicki, A; Pawlak, M; Piotrowska-Kempisty, H; Rolle, K; Skupin-Mrugalska, P; Wawrzyniak, D; Wierzchowski, M | 1 |
| Bryja, A; Czajkowski, M; Gogola-Mruk, J; Józkowiak, M; Kempisty, B; Kobylarek, D; Piotrowska-Kempisty, H; Skupin-Mrugalska, P; Spaczyński, RZ | 1 |
| Go, ML; Zhang, W | 2 |
| Alam, MS; Ismail, T; Khazir, J; Kumar, HM; Qurishi, Y; Sarkar, D; Shafi, S; Srinivas, J | 1 |
16 other study(ies) available for resveratrol and 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene
| Article | Year |
|---|---|
Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Chemoprevention; Colorectal Neoplasms; Drug Design; Hydroxylation; Isomerism; Mice; Resveratrol; Stilbenes; Tissue Distribution | 2004 |
A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts.
Topics: Apoptosis; Cell Division; Cell Line, Transformed; Fibroblasts; Humans; Mitochondria; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2005 |
Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.
Topics: Adenoma; Animals; Antineoplastic Agents, Phytogenic; Chemoprevention; Colonic Neoplasms; Cyclooxygenase 2; Diet; Dinoprostone; Female; Genes, APC; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; Resveratrol; Ribonucleotide Reductases; Stilbenes; Tissue Distribution | 2005 |
Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Biopolymers; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Estrogens; Female; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Resveratrol; STAT3 Transcription Factor; Stilbenes; Tubulin | 2008 |
Trans-3,4,5,4'-tetramethoxystilbene, a resveratrol analog, potently inhibits angiogenesis in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Chick Embryo; Dose-Response Relationship, Drug; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Resveratrol; Stilbenes | 2013 |
Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue.
Topics: Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Caspases; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Humans; Resveratrol; Stilbenes | 2013 |
Heteroaromatic analogs of the resveratrol analog DMU-212 as potent anti-cancer agents.
Topics: Antineoplastic Agents; Benzofurans; Benzothiazoles; Binding Sites; Cell Line, Tumor; Cell Survival; Colchicine; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Protein Structure, Tertiary; Resveratrol; Stilbenes; Thiophenes; Tubulin | 2015 |
Effect of resveratrol analogue, DMU-212, on antioxidant status and apoptosis-related genes in rat model of hepatocarcinogenesis.
Topics: Animals; Antioxidants; Apoptosis; Liver Neoplasms, Experimental; Male; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2017 |
3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Genome, Human; Humans; Metabolome; Mice; Mice, SCID; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Real-Time Polymerase Chain Reaction; Resveratrol; Signal Transduction; Stilbenes; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
Hydroxystilbenes and methoxystilbenes activate human aryl hydrocarbon receptor and induce CYP1A genes in human hepatoma cells and human hepatocytes.
Topics: Adult; Aged; Basic Helix-Loop-Helix Transcription Factors; Cells, Cultured; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inducers; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Isomerism; Male; Middle Aged; Receptors, Aryl Hydrocarbon; Resveratrol; Stilbenes | 2017 |
The Effect of 3'-Hydroxy-3,4,5,4'-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of Ovarian Cancer Cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Kruppel-Like Factor 4; Ovarian Neoplasms; Resveratrol; Stilbenes; Transcriptome | 2020 |
Enhanced biological activity of liposomal methylated resveratrol analog 3'-hydroxy-3,4,5,4'-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Liposomes; Ovarian Neoplasms; Resveratrol; Stilbenes | 2022 |
Steroidogenic activity of liposomal methylated resveratrol analog 3,4,5,4'-tetramethoxystilbene (DMU-212) in human luteinized granulosa cells in a primary three-dimensional in vitro model.
Topics: Cholesterol Side-Chain Cleavage Enzyme; Estradiol; Female; Follicle Stimulating Hormone; Granulosa Cells; Humans; Liposomes; Multienzyme Complexes; Progesterone; Resveratrol; Stilbenes | 2023 |
Quinone reductase induction activity of methoxylated analogues of resveratrol.
Topics: Animals; Antineoplastic Agents; Antioxidants; Biomarkers; Cell Line, Tumor; Enzyme Induction; Mice; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Resveratrol; Stilbenes | 2007 |
Methoxylation of resveratrol: effects on induction of NAD(P)H quinone-oxidoreductase 1 (NQO1) activity and growth inhibitory properties.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Mice; NAD(P)H Dehydrogenase (Quinone); Resveratrol; Stilbenes; Structure-Activity Relationship | 2011 |
Synthesis and tyrosinase inhibition activity of trans-stilbene derivatives.
Topics: Animals; Cell Line, Tumor; Enzyme Inhibitors; Mice; Monophenol Monooxygenase; Resveratrol; Stilbenes; Structure-Activity Relationship | 2016 |